CID 11184826

(4as,10br)-noroxomaritidine

Structural Information

Molecular Formula
C16H17NO3
SMILES
COC1=C(C=C2CN3CC[C@]4([C@@H]3CC(=O)C=C4)C2=C1)O
InChI
InChI=1S/C16H17NO3/c1-20-14-8-12-10(6-13(14)19)9-17-5-4-16(12)3-2-11(18)7-15(16)17/h2-3,6,8,15,19H,4-5,7,9H2,1H3/t15-,16-/m0/s1
InChIKey
VEXDOCFQMVMPHJ-HOTGVXAUSA-N
Compound name
(1R,10S)-5-hydroxy-4-methoxy-9-azatetracyclo[7.5.2.01,10.02,7]hexadeca-2,4,6,13-tetraen-12-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

2
References

0
Patents

271.12085 Da
Monoisotopic Mass

1.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 272.128126 161.0
[M+Na]+ 294.110068 169.5
[M-H]- 270.113574 164.8
[M+NH4]+ 289.154673 182.0
[M+K]+ 310.084008 164.7
[M+H-H2O]+ 254.118110 153.8
[M+HCOO]- 316.119051 176.1
[M+CH3COO]- 330.134701 172.4
[M+Na-2H]- 292.095516 165.3
[M]+ 271.12030142 159.9
[M]- 271.12139858 159.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.